Urica Therapeutics
Bay Harbor Islands, US · Delaware corporation
Founders & leadership
RZ
Raymond ZhengNamed on SEC filing
JD
Jay D Kranzler, M.D., Ph.D.Named on SEC filing
VS
Vibeke Strand, M.D.Named on SEC filing
Board
MS
Michael S. WeissBoard director
LA
Lindsay A. Rosenwald, M.D.Board director
Reported raises · per SEC filings
Form D private placements$2.5M disclosed across 1 round · 2022
▶$2.5MraisedJan 2023 · 26 investors · BiotechnologyRule 506(b)
▶$2.5MraisedJan 2023 · 26 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Raymond ZhengExecutive Officer, Director
- Jay D Kranzler, M.D., Ph.D.Executive Officer, Director
- Michael S. WeissDirector
- Vibeke Strand, M.D.Director
- Lindsay A. Rosenwald, M.D.Director
- Offering amount
- $5M
- Amount sold
- $2.5M
- Sales commissions
- $253.3K
- Placement agents
- Harley Capital LLC
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Urica Therapeutics raised?
- Urica Therapeutics has disclosed $2.5M raised across 1 round.
- Where is Urica Therapeutics headquartered?
- Urica Therapeutics is headquartered in Bay Harbor Islands, US.